Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. - Wikidata - wikimedia - TriplyDB

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

http://www.wikidata.org/entity/Q34443382

about

Efficacy of Psychostimulant Drugs for Cocaine Dependence Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders Agonist replacement for stimulant dependence: a review of clinical research Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials Safety of therapeutic methylphenidate in adults: a systematic review of the evidence Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.Agonist replacement therapy for cocaine dependence: a translational review.An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.Substance-use disorders in adolescents and adults with ADHD: focus on treatment.Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.Treatment strategies for co-occurring ADHD and substance use disorders Treatment of adult ADHD: is current knowledge useful to clinicians?Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.Cognitive-Behavioral Therapy for ADHD in Adolescents: Clinical Considerations and a Case Series.Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride.Comorbid psychiatric and substance abuse disorders: recent treatment research.Distinguishing comorbidity and successful management of adult ADHD.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Toward quality care in ADHD: defining the goals of treatment.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review.

P2860

Q24239994-75B96B98-D8E0-4552-8307-2B553E1F31C3 Q26777710-7135DA6C-9334-42C2-AF7B-6F93D6804843 Q26851607-D18BC2D5-60F0-4E37-8AE4-E4B446887339 Q27014854-832B65D2-571A-4FCE-A020-9F83CB5AA4FA Q28246506-18627EBD-36BA-4263-ACE4-C45EAD80D719 Q28255609-2A2B5347-D297-4E25-8A5B-4FC6FDB74B80 Q28282264-04497381-C154-4B45-99E7-3F3F7F72BFC2 Q33574891-8E6FFD42-8DDE-4E16-B712-20B3BAC00E96 Q33876388-82B35D03-D28F-43DF-A2B7-7F86A57D247F Q33919950-4EEC9467-F5F8-414A-8231-82E318166172 Q33957119-8B95FBE7-0875-4F2F-BC10-082EFD50B379 Q34041736-B72F73E1-A556-45CA-A6A7-B3D9165367F9 Q34060576-2672C998-17A5-4723-B32F-B59D36609679 Q34220004-05205153-644B-4FB0-8CC5-AE3E79CE7D17 Q34481951-F920F3BE-B11A-4B5C-8BB5-A14259E49D31 Q34487773-71E76895-A662-437F-B6C4-1750D30F801A Q34497314-E601A1C8-3369-41F3-AF7D-C435EBD84892 Q34714758-C6D71AF4-BFE2-4084-815F-1A833AF6B593 Q35189691-3E886322-F849-4B29-BEDE-AC2DC78276C5 Q35766564-F4DD45C3-47C5-4481-899D-865F3C5DC830 Q35799846-893A4A2D-7B9E-4560-9276-4772FE994AAA Q35878684-B7669713-D278-47CF-AC95-CBA478638EA5 Q36344412-C2106EEE-1C99-4C2B-B98D-27DC45932A86 Q36453288-F017079E-A422-4BBE-BA64-909ED871FE00 Q36478373-1E4C0DB5-5D75-4AF3-931D-B2BD334FDBC7 Q36799361-E28E5377-1A89-4190-93C2-D5F8A46EF5D0 Q36836781-5A2650F4-F50A-4A95-AB41-F098C856FBF7 Q37169714-8E501FAB-FDB0-42F5-8841-D7231600A693 Q37185366-B6F77D22-8F43-4A0D-944A-56C57EE389D7 Q37194205-DBE54CED-23CA-4B33-BB76-3B58DC541E5A Q37238639-883DB6F9-98EB-4F4C-8458-E2CACDE50E15 Q37318744-8F0F0D81-3AC3-405D-84AC-E7EF4764C171 Q37337682-8D9DF240-5CBD-4FD4-BCD9-943B63D3CEA3 Q38002290-8A4EC1B2-138F-4273-B923-EFD211A87F98 Q38065287-1A91A73C-6E91-49F8-9801-B9843AFBC9C4 Q38082894-6906D17C-C475-4CAA-A6C4-C8BBAF0DC546 Q38239633-281334F4-9DD4-4D1E-B11B-BB717E30D64A Q38241724-F30E7A94-1C4C-4190-A699-C1DE6375869D Q38243174-CCE93305-449D-4093-B090-E8A4CC87566B Q38714397-BBFA20F1-F6E7-4991-82ED-400C90DEC3B5

P2860

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

http://www.wikidata.org/entity/Q34443382

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@ast

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@en

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@nl

type

label

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@ast

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@en

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@nl

prefLabel

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@ast

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@en

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@nl

P1433

Q34443382-A500BC3A-BC7D-4C23-B998-B3F26AB6DA41

P1476

Q34443382-02DCA303-86FF-4E92-86FF-90EBF88BEE63

P2093

Q34443382-1FB5439D-5A65-4230-87BA-EDAD46522913

Q34443382-386C84D1-26E2-454F-BF9B-6DCC692F6665

Q34443382-737B8FC2-F5F0-4C3E-8D99-DC84C64E35CD

Q34443382-8E84129C-D3C2-46A8-8FA3-213FDDEB83C9

Q34443382-A618AA0C-7998-4013-8641-6221786FB06F

Q34443382-A79F4838-F9E6-4C76-B2D7-683C3229DC96

P304

Q34443382-925111EB-0BFF-455D-AA22-2A129300C2E9

P31

Q34443382-FBD0C219-392F-40B5-968E-E570BF4D4BB7

P356

Q34443382-5C8543C1-79E5-42B6-8DB5-548C499B9E1A

P433

Q34443382-5229DFF6-6880-461B-AB5E-ABE013FE718C

P478

Q34443382-4E0B42F1-47FF-4244-863D-2D5906660ABB

P577

Q34443382-82C6517C-28E1-4932-A28E-FBBAC58AE850

P698

Q34443382-7DC18144-151E-4152-847C-6F32AF60502E

P921

Q34443382-8335BA13-C933-491E-AC7F-AB996B02A138

Q34443382-FACC2225-8DCE-41CC-BAAF-9657B573F535

P356

J.DRUGALCDEP.2005.06.012

P1433

Drug and Alcohol Dependence

P1476

Treatment of methadone-maintai ...... nidate, bupropion and placebo.

@en

P2093

Aparna S Kalbag

http://www.w3.org/2001/XMLSchema#string

Daniel J Brooks

http://www.w3.org/2001/XMLSchema#string

Edward V Nunes

http://www.w3.org/2001/XMLSchema#string

Fatima Garawi

http://www.w3.org/2001/XMLSchema#string

Frances R Levin

http://www.w3.org/2001/XMLSchema#string

Suzette M Evans

http://www.w3.org/2001/XMLSchema#string

P304

137-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2005.06.012

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16102908

http://www.w3.org/2001/XMLSchema#string

P921